M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical TechnologyMerck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences. M&A / DealsRead full story Post navigation Previous: Alzheimer’s biotech Korsana to go public via reverse mergerNext: Threat of Trump’s pharma tariffs looms again Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026